Ikonisys S.A.

ALIKO.PA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ALIKO.PA stands at 22.07M. In comparison, PHIA.AS has a market cap of 20.32B. Regarding current trading prices, ALIKO.PA is priced at $1.58, while PHIA.AS trades at $21.97.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ALIKO.PA currently has a P/E ratio of -6.08, whereas PHIA.AS's P/E ratio is 84.50. In terms of profitability, ALIKO.PA's ROE is -0.17%, compared to PHIA.AS's ROE of -0.06%. Regarding short-term risk, ALIKO.PA is less volatile compared to PHIA.AS. This indicates potentially lower risk in terms of short-term price fluctuations for ALIKO.PA.

ALIKO.PA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ALIKO.PA stands at 22.07M. In comparison, IBAB.BR has a market cap of 338.66M. Regarding current trading prices, ALIKO.PA is priced at $1.58, while IBAB.BR trades at $11.56.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ALIKO.PA currently has a P/E ratio of -6.08, whereas IBAB.BR's P/E ratio is 42.81. In terms of profitability, ALIKO.PA's ROE is -0.17%, compared to IBAB.BR's ROE of +0.09%. Regarding short-term risk, ALIKO.PA is less volatile compared to IBAB.BR. This indicates potentially lower risk in terms of short-term price fluctuations for ALIKO.PA.

ALIKO.PA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ALIKO.PA stands at 22.07M. In comparison, GBT.PA has a market cap of 267.19M. Regarding current trading prices, ALIKO.PA is priced at $1.58, while GBT.PA trades at $21.20.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ALIKO.PA currently has a P/E ratio of -6.08, whereas GBT.PA's P/E ratio is 19.81. In terms of profitability, ALIKO.PA's ROE is -0.17%, compared to GBT.PA's ROE of +0.04%. Regarding short-term risk, ALIKO.PA is less volatile compared to GBT.PA. This indicates potentially lower risk in terms of short-term price fluctuations for ALIKO.PA.

ALIKO.PA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ALIKO.PA stands at 22.07M. In comparison, EAPI.PA has a market cap of 262.83M. Regarding current trading prices, ALIKO.PA is priced at $1.58, while EAPI.PA trades at $2.76.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ALIKO.PA currently has a P/E ratio of -6.08, whereas EAPI.PA's P/E ratio is -2.00. In terms of profitability, ALIKO.PA's ROE is -0.17%, compared to EAPI.PA's ROE of -0.14%. Regarding short-term risk, ALIKO.PA is less volatile compared to EAPI.PA. This indicates potentially lower risk in terms of short-term price fluctuations for ALIKO.PA.

ALIKO.PA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ALIKO.PA stands at 22.07M. In comparison, ALERS.PA has a market cap of 253.14M. Regarding current trading prices, ALIKO.PA is priced at $1.58, while ALERS.PA trades at $25.30.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ALIKO.PA currently has a P/E ratio of -6.08, whereas ALERS.PA's P/E ratio is 64.87. In terms of profitability, ALIKO.PA's ROE is -0.17%, compared to ALERS.PA's ROE of +0.02%. Regarding short-term risk, ALIKO.PA is more volatile compared to ALERS.PA. This indicates potentially higher risk in terms of short-term price fluctuations for ALIKO.PA.

ALIKO.PA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ALIKO.PA stands at 22.07M. In comparison, ALCOR.PA has a market cap of 154.53M. Regarding current trading prices, ALIKO.PA is priced at $1.58, while ALCOR.PA trades at $35.10.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ALIKO.PA currently has a P/E ratio of -6.08, whereas ALCOR.PA's P/E ratio is -234.00. In terms of profitability, ALIKO.PA's ROE is -0.17%, compared to ALCOR.PA's ROE of -0.23%. Regarding short-term risk, ALIKO.PA is more volatile compared to ALCOR.PA. This indicates potentially higher risk in terms of short-term price fluctuations for ALIKO.PA.

ALIKO.PA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ALIKO.PA stands at 22.07M. In comparison, SEQUA.BR has a market cap of 57.70M. Regarding current trading prices, ALIKO.PA is priced at $1.58, while SEQUA.BR trades at $1.08.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ALIKO.PA currently has a P/E ratio of -6.08, whereas SEQUA.BR's P/E ratio is -1.19. In terms of profitability, ALIKO.PA's ROE is -0.17%, compared to SEQUA.BR's ROE of +2.05%. Regarding short-term risk, ALIKO.PA is less volatile compared to SEQUA.BR. This indicates potentially lower risk in terms of short-term price fluctuations for ALIKO.PA.

ALIKO.PA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ALIKO.PA stands at 22.07M. In comparison, AFME.PA has a market cap of 52.14M. Regarding current trading prices, ALIKO.PA is priced at $1.58, while AFME.PA trades at $1.33.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ALIKO.PA currently has a P/E ratio of -6.08, whereas AFME.PA's P/E ratio is -3.50. In terms of profitability, ALIKO.PA's ROE is -0.17%, compared to AFME.PA's ROE of -0.51%. Regarding short-term risk, ALIKO.PA is less volatile compared to AFME.PA. This indicates potentially lower risk in terms of short-term price fluctuations for ALIKO.PA.

ALIKO.PA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ALIKO.PA stands at 22.07M. In comparison, ALCAR.PA has a market cap of 47.00M. Regarding current trading prices, ALIKO.PA is priced at $1.58, while ALCAR.PA trades at $0.80.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ALIKO.PA currently has a P/E ratio of -6.08, whereas ALCAR.PA's P/E ratio is -0.69. In terms of profitability, ALIKO.PA's ROE is -0.17%, compared to ALCAR.PA's ROE of +1.40%. Regarding short-term risk, ALIKO.PA is more volatile compared to ALCAR.PA. This indicates potentially higher risk in terms of short-term price fluctuations for ALIKO.PA.

ALIKO.PA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ALIKO.PA stands at 22.07M. In comparison, ALMDT.PA has a market cap of 43.21M. Regarding current trading prices, ALIKO.PA is priced at $1.58, while ALMDT.PA trades at $2.27.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ALIKO.PA currently has a P/E ratio of -6.08, whereas ALMDT.PA's P/E ratio is -1.65. In terms of profitability, ALIKO.PA's ROE is -0.17%, compared to ALMDT.PA's ROE of +0.90%. Regarding short-term risk, ALIKO.PA is less volatile compared to ALMDT.PA. This indicates potentially lower risk in terms of short-term price fluctuations for ALIKO.PA.

ALIKO.PA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ALIKO.PA stands at 22.07M. In comparison, ALNOV.PA has a market cap of 32.98M. Regarding current trading prices, ALIKO.PA is priced at $1.58, while ALNOV.PA trades at $0.47.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ALIKO.PA currently has a P/E ratio of -6.08, whereas ALNOV.PA's P/E ratio is -0.77. In terms of profitability, ALIKO.PA's ROE is -0.17%, compared to ALNOV.PA's ROE of -0.23%. Regarding short-term risk, ALIKO.PA is less volatile compared to ALNOV.PA. This indicates potentially lower risk in terms of short-term price fluctuations for ALIKO.PA.

ALIKO.PA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ALIKO.PA stands at 22.07M. In comparison, MKEA.PA has a market cap of 30.17M. Regarding current trading prices, ALIKO.PA is priced at $1.58, while MKEA.PA trades at $0.62.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ALIKO.PA currently has a P/E ratio of -6.08, whereas MKEA.PA's P/E ratio is -2.49. In terms of profitability, ALIKO.PA's ROE is -0.17%, compared to MKEA.PA's ROE of +0.74%. Regarding short-term risk, ALIKO.PA is more volatile compared to MKEA.PA. This indicates potentially higher risk in terms of short-term price fluctuations for ALIKO.PA.

ALIKO.PA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ALIKO.PA stands at 22.07M. In comparison, ALDMS.PA has a market cap of 19.21M. Regarding current trading prices, ALIKO.PA is priced at $1.58, while ALDMS.PA trades at $1.06.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ALIKO.PA currently has a P/E ratio of -6.08, whereas ALDMS.PA's P/E ratio is -8.17. In terms of profitability, ALIKO.PA's ROE is -0.17%, compared to ALDMS.PA's ROE of -0.25%. Regarding short-term risk, ALIKO.PA is less volatile compared to ALDMS.PA. This indicates potentially lower risk in terms of short-term price fluctuations for ALIKO.PA.

ALIKO.PA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ALIKO.PA stands at 22.07M. In comparison, ALTER.PA has a market cap of 17.29M. Regarding current trading prices, ALIKO.PA is priced at $1.58, while ALTER.PA trades at $1.26.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ALIKO.PA currently has a P/E ratio of -6.08, whereas ALTER.PA's P/E ratio is 42.00. In terms of profitability, ALIKO.PA's ROE is -0.17%, compared to ALTER.PA's ROE of -0.06%. Regarding short-term risk, ALIKO.PA is less volatile compared to ALTER.PA. This indicates potentially lower risk in terms of short-term price fluctuations for ALIKO.PA.

ALIKO.PA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ALIKO.PA stands at 22.07M. In comparison, ALTHE.PA has a market cap of 13.56M. Regarding current trading prices, ALIKO.PA is priced at $1.58, while ALTHE.PA trades at $0.29.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ALIKO.PA currently has a P/E ratio of -6.08, whereas ALTHE.PA's P/E ratio is -2.25. In terms of profitability, ALIKO.PA's ROE is -0.17%, compared to ALTHE.PA's ROE of -1.29%. Regarding short-term risk, ALIKO.PA is less volatile compared to ALTHE.PA. This indicates potentially lower risk in terms of short-term price fluctuations for ALIKO.PA.

ALIKO.PA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ALIKO.PA stands at 22.07M. In comparison, ALIMP.PA has a market cap of 12.66M. Regarding current trading prices, ALIKO.PA is priced at $1.58, while ALIMP.PA trades at $0.10.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ALIKO.PA currently has a P/E ratio of -6.08, whereas ALIMP.PA's P/E ratio is -2.53. In terms of profitability, ALIKO.PA's ROE is -0.17%, compared to ALIMP.PA's ROE of -2.06%. Regarding short-term risk, ALIKO.PA is less volatile compared to ALIMP.PA. This indicates potentially lower risk in terms of short-term price fluctuations for ALIKO.PA.

ALIKO.PA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ALIKO.PA stands at 22.07M. In comparison, ALEMG.PA has a market cap of 11.22M. Regarding current trading prices, ALIKO.PA is priced at $1.58, while ALEMG.PA trades at $3.95.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ALIKO.PA currently has a P/E ratio of -6.08, whereas ALEMG.PA's P/E ratio is 26.31. In terms of profitability, ALIKO.PA's ROE is -0.17%, compared to ALEMG.PA's ROE of +0.81%. Regarding short-term risk, ALIKO.PA is more volatile compared to ALEMG.PA. This indicates potentially higher risk in terms of short-term price fluctuations for ALIKO.PA.

ALIKO.PA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ALIKO.PA stands at 22.07M. In comparison, ALBLU.PA has a market cap of 7.61M. Regarding current trading prices, ALIKO.PA is priced at $1.58, while ALBLU.PA trades at $0.62.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ALIKO.PA currently has a P/E ratio of -6.08, whereas ALBLU.PA's P/E ratio is -6.20. In terms of profitability, ALIKO.PA's ROE is -0.17%, compared to ALBLU.PA's ROE of -0.61%. Regarding short-term risk, ALIKO.PA is less volatile compared to ALBLU.PA. This indicates potentially lower risk in terms of short-term price fluctuations for ALIKO.PA.

ALIKO.PA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ALIKO.PA stands at 22.07M. In comparison, ALSGD.PA has a market cap of 6.53M. Regarding current trading prices, ALIKO.PA is priced at $1.58, while ALSGD.PA trades at $0.11.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ALIKO.PA currently has a P/E ratio of -6.08, whereas ALSGD.PA's P/E ratio is -1.17. In terms of profitability, ALIKO.PA's ROE is -0.17%, compared to ALSGD.PA's ROE of -0.59%. Regarding short-term risk, ALIKO.PA is less volatile compared to ALSGD.PA. This indicates potentially lower risk in terms of short-term price fluctuations for ALIKO.PA.